Biologists Identify New Targets for Cancer Vaccines

Written by Anil Bajnath, MD
Posted September 27, 2021

Dear Longevity Insider,

Anil Bajnath MD here with your Monday roundup.

Live long enough, and you’ve probably known someone who was diagnosed with cancer. For the past 10 years, scientists have riggorously explored how to fight cancer with a vaccine.

While the FDA hasn’t approved any of these cancer vaccines, some show promise in clinical trials to treat some types of lung cancer and melanoma.

And a recent study just identified new targets for these types of vaccines.

Tyler Jacks, the David H. Koch Professor of Biology, a member of the Koch Institute for Integrative Cancer Research, adds:

This study highlights the importance of exploring the details of immune responses against cancer deeply. We can now see that not all anticancer immune responses are created equal, and that vaccination can unleash a potent response against a target that was otherwise effectively ignored.

So  what’s this team of biologists’ latest discovery on fighting cancer?

Like and follow my new social media pages to find out:
                                                                           
                                                                               facebook logo      twitter social icon
                                                                                   Facebook                   Twitter

 
I promise you, this is a story you can't afford to miss. I'll see you in social media land!

To your longevity,
Anil Bajnath MD Signature


Anil Bajnath MD
CEO/Founder, Institute for Human Optimization

Chief Medical Officer, Longevity Insider HQ

P.S. Studies prove that many of today’s diseases and ailments stem from toxic cells in your body. Here’s my latest research on how those cells form and a method used to flush them out of the system.